New Insights Into the Role of mTOR Signaling in the Cardiovascular System
- PMID: 29420210
- PMCID: PMC6398933
- DOI: 10.1161/CIRCRESAHA.117.311147
New Insights Into the Role of mTOR Signaling in the Cardiovascular System
Abstract
The mTOR (mechanistic target of rapamycin) is a master regulator of several crucial cellular processes, including protein synthesis, cellular growth, proliferation, autophagy, lysosomal function, and cell metabolism. mTOR interacts with specific adaptor proteins to form 2 multiprotein complexes, called mTORC1 (mTOR complex 1) and mTORC2 (mTOR complex 2). In the cardiovascular system, the mTOR pathway regulates both physiological and pathological processes in the heart. It is needed for embryonic cardiovascular development and for maintaining cardiac homeostasis in postnatal life. Studies involving mTOR loss-of-function models revealed that mTORC1 activation is indispensable for the development of adaptive cardiac hypertrophy in response to mechanical overload. mTORC2 is also required for normal cardiac physiology and ensures cardiomyocyte survival in response to pressure overload. However, partial genetic or pharmacological inhibition of mTORC1 reduces cardiac remodeling and heart failure in response to pressure overload and chronic myocardial infarction. In addition, mTORC1 blockade reduces cardiac derangements induced by genetic and metabolic disorders and has been reported to extend life span in mice. These studies suggest that pharmacological targeting of mTOR may represent a therapeutic strategy to confer cardioprotection, although clinical evidence in support of this notion is still scarce. This review summarizes and discusses the new evidence on the pathophysiological role of mTOR signaling in the cardiovascular system.
Keywords: autophagy; cardiovascular diseases; heart; hypertrophy; mice.
© 2018 American Heart Association, Inc.
Conflict of interest statement
Figures





Similar articles
-
Mammalian target of rapamycin signaling in cardiac physiology and disease.Circ Res. 2014 Jan 31;114(3):549-64. doi: 10.1161/CIRCRESAHA.114.302022. Circ Res. 2014. PMID: 24481845 Free PMC article. Review.
-
The complex network of mTOR signalling in the heart.Cardiovasc Res. 2022 Jan 29;118(2):424-439. doi: 10.1093/cvr/cvab033. Cardiovasc Res. 2022. PMID: 33512477 Free PMC article. Review.
-
Canonical signaling and nuclear activity of mTOR-a teamwork effort to regulate metabolism and cell growth.FEBS J. 2018 May;285(9):1572-1588. doi: 10.1111/febs.14384. Epub 2018 Jan 31. FEBS J. 2018. PMID: 29337437 Review.
-
Loss of mTOR signaling affects cone function, cone structure and expression of cone specific proteins without affecting cone survival.Exp Eye Res. 2015 Jun;135:1-13. doi: 10.1016/j.exer.2015.04.006. Epub 2015 Apr 14. Exp Eye Res. 2015. PMID: 25887293 Free PMC article.
-
[Roles of mTOR in ageing and longevity].Nihon Rinsho. 2016 Sep;74(9):1479-1484. Nihon Rinsho. 2016. PMID: 30557480 Review. Japanese.
Cited by
-
mTOR in the Development of Hypoxic Pulmonary Hypertension Associated with Cardiometabolic Risk Factors.Int J Mol Sci. 2024 Oct 14;25(20):11023. doi: 10.3390/ijms252011023. Int J Mol Sci. 2024. PMID: 39456805 Free PMC article. Review.
-
GQ262 Attenuates Pathological Cardiac Remodeling by Downregulating the Akt/mTOR Signaling Pathway.Int J Mol Sci. 2024 Sep 25;25(19):10297. doi: 10.3390/ijms251910297. Int J Mol Sci. 2024. PMID: 39408627 Free PMC article.
-
CHIR99021 Augmented the Function of Late Endothelial Progenitor Cells by Preventing Replicative Senescence.Int J Mol Sci. 2021 Apr 30;22(9):4796. doi: 10.3390/ijms22094796. Int J Mol Sci. 2021. PMID: 33946516 Free PMC article.
-
The role of autophagy in the progression of HIV infected cardiomyopathy.Front Cell Dev Biol. 2024 Jul 17;12:1372573. doi: 10.3389/fcell.2024.1372573. eCollection 2024. Front Cell Dev Biol. 2024. PMID: 39086659 Free PMC article. Review.
-
Endothelial EphB4 maintains vascular integrity and transport function in adult heart.Elife. 2019 Nov 29;8:e45863. doi: 10.7554/eLife.45863. Elife. 2019. PMID: 31782728 Free PMC article.
References
-
- Brown EJ, Albers MW, Shin TB, Ichikawa K, Keith CT, Lane WS, Schreiber SL. A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature. 1994;369:756–8. - PubMed
-
- Sabatini DM, Erdjument-Bromage H, Lui M, Tempst P, Snyder SH. RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs. Cell. 1994;78:35–43. - PubMed
-
- Sabers CJ, Martin MM, Brunn GJ, Williams JM, Dumont FJ, Wiederrecht G, Abraham RT. Isolation of a protein target of the FKBP12-rapamycin complex in mammalian cells. J Biol Chem. 1995;270:815–22. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous